Accumulating evidence suggests that MAGEC2 influences the progression and metastasis of breast cancer and other solid tumors (21–25) by mechanisms that include the promotion of epithelial-to-mesenchymal transition (23, 24), p53 stability (26) and stabilization of the activated form of STAT3 (27). The gene discussed is MAGEC2; the disease is breast carcinoma.